ReviewMedicina (Kaunas, Lithuania)2025
Advances in Prenatal Diagnosis of Placenta Accreta Spectrum.
Review in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Evaluating a novel approach to placenta accreta spectrum management: the modified Triple-P technique with cystoinflation (a randomized controlled trial).Scientific reports · 2025Trial
- The Role of Interventional Radiology in the Diagnosis and Treatment of Gynecological Conditions.Tomography (Ann Arbor, Mich.) · 2026Review
- Maternal serum thrombospondin-4 levels in placenta accreta spectrum: A case-control study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026Article
- The quintessential high-risk profile: advanced management strategies for placenta accreta spectrum in patients with advanced maternal age and IVF conception.BMC pregnancy and childbirth · 2026Review
- Placenta Accreta Spectrum: Diagnostic Challenges and Management Strategies.Diagnostics (Basel, Switzerland) · 2026Review
- Simple conservative surgery for placenta accreta spectrum without parametrial invasion: a novel uterus-sparing approach.AJOG global reports · 2026Article
- Article
- DARIP Technique: A Novel Approach in the Surgical Management of Placenta Accreta Spectrum in the Second Trimester From Tu Du Hospital, Vietnam.Case reports in obstetrics and gynecology · 2026Article
- Applicability of an ultrasound scoring system for predicting hemorrhage during cesarean section in patients with placenta accreta spectrum disorders.Frontiers in medicine · 2026Article
- Ultrasound-guided caesarean section as a safer intraoperative strategy for vasa previa type III: A case report.Case reports in women's health · 2025Article
- Prognostic Significance of Serial Ultrasonography in Placenta Accreta Spectrum and Its Impact on Perinatal Outcomes.Medicina (Kaunas, Lithuania) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Placenta accreta spectrum (PAS) involves abnormal placental attachment and can lead to severe complications such as postpartum hemorrhage and hysterectomy. Ultrasound is the main tool used to screen for PAS due to its non-invasive nature and convenience, although its accuracy depends on the skill of the operator. Magnetic Resonance Imaging has emerged as a supplementary tool, especially for complex cases or posterior placentas, providing more accurate anatomical detail and enabling the invasion depth and location to be assessed. This review summarizes recent advances in prenatal imaging for PAS, aiming to improve diagnostic accuracy and guide future research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.